CompaniesGammaDelta Therapeutics

GammaDelta Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

3

By Phase

PHASE1: 1

By Status

TERMINATED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
Today
NCT05001451
Hover over trial bars to see details

Recent Trials

NCT05001451Lead Sponsor
Study of GDX012 in Patients With MRD Positive AML
PHASE1Terminated
3 participants
Started: Aug 13, 2021 · Completed: Jun 3, 2022
Related Companies
Takeda
acquired